title: Proteasome inhibition leads to dephosphorylation and downregulation of protein expression of members of the Akt/mTOR pathway in MCL.
authors.forename: G
authors.initials: G
authors.lastname: Hutter
authors.forename: Y
authors.initials: Y
authors.lastname: Zimmermann
authors.forename: M
authors.initials: M
authors.lastname: Rieken
authors.forename: E
authors.initials: E
authors.lastname: Hartmann
authors.forename: A
authors.initials: A
authors.lastname: Rosenwald
authors.forename: W
authors.initials: W
authors.lastname: Hiddemann
authors.forename: M
authors.initials: M
authors.lastname: Dreyling
mesh_terms: D015536:Down-Regulation; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000201:enzymology / Q000378:metabolism* / Q000473:pathology; D009363:Neoplasm Proteins / Q000235:genetics; D010766:Phosphorylation; D046988:Proteasome Endopeptidase Complex / Q000187:drug effects*; D061988:Proteasome Inhibitors / Q000494:pharmacology*; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism*; D058570:TOR Serine-Threonine Kinases / Q000378:metabolism*
chemical_list: D009363:Neoplasm Proteins; D061988:Proteasome Inhibitors; D051057:Proto-Oncogene Proteins c-akt; D058570:TOR Serine-Threonine Kinases; D046988:Proteasome Endopeptidase Complex